Matching slides 42,534
Current window 31,951-31,980
Pages 1,418
Rows per page 30
Beat: Resolutionclear collectionreset all

Beat

31,951-31,980 of 42,534

filter-aware
34
23andMe | Investor Presentation Deck | 39 slides23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
35
The slide uses a process-flow diagram at the bottom to map team expertise to the drug discovery pipeline.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
36
Uses a Venn-like diagram to show genetic overlap between asthma and other conditions (COPD, eczema, neuro-inflammation, urticaria) to drive specific R&D strategies.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
37
Uses a bell curve distribution to illustrate the selection strategy for cases and controls.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
38
The slide uses a table to categorize biological targets by cell type and associated disease indications.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
39
23andMe | Investor Presentation Deck | 39 slides23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
07
The slide uses a circular process diagram to link AI design with wet-lab validation.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
08
The slide uses a linear process flow with icons representing the transformation of biological inputs through AI models.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
09
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
10
The right side uses a dot-plot style visualization to represent the economic structure of a partnership, moving from R&D funding to commercial royalties.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
11
The slide uses a Venn diagram to categorize partnerships. The 'Internal Asset Pipeline' section includes a small table/chart showing three programs (ABS-101, ABS-201, ABS-301).Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
12
The slide uses a Gantt-style chart to show the progress of three assets (ABS-101, ABS-201, ABS-301) across development stages.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
13
The slide uses a split-screen approach: biological mechanism on the left, market sizing on the right.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
14
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
15
Uses a before-after framing to show how affinity translates to potency.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
16
The slide uses a before-after structure to demonstrate the superiority of the ABS-101 platform over competitors (RVT-3101, MK-7240).Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
17
The visual shows a 3D protein structure with highlighted binding regions for various antibodies.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
18
The table uses checkmarks and crosses to indicate the presence or absence of specific therapeutic attributes across four different drug programs.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
19
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
20
Includes logos of partner/talent source institutions and photos of the team and lab facilities.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
14
The slide uses a numbered list format to present strategic growth pillars over a background image.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
26
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · Resolution1 hit
27
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · Resolution1 hit
28
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · Resolution1 hit
29
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · Resolution1 hit
08
The slide uses a process-oriented flow diagram to explain the therapeutic strategy.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
09
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
10
The slide highlights the mechanism of action and key benefits of the drug candidate.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
11
Data presented at EASL 2022, AASLD 2022, GHS 2023.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
12
Data presented at EASL 2022. Shows dual-axis line charts for viral load/ALT and bar charts for T-cell frequency.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit